Clinical Trial Update: Lapelga vs Gastrofil [Phase 3]

View source ↗

Summary

Phase 3 trial update for Lapelga versus Gastrofil in patients with Multiple Myeloma and Lymphoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Gastrofil
• Lapelga

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Multiple Myeloma, Lymphoma | Phase 3 | Status: UNKNOWN